General Information of the Compound
| Compound ID |
CP0089024
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-hydroxy-4H-isoquinoline-1,3-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
0637AC
0N7
1,3(2H,4H)-Isoquinolinedione, 2-hydroxy-
2-Hydroxy-1,3(2H,4H)-isoquinolinedione
2-Hydroxy-4H-isoquinoline-1,3-dione
2-hydroxy-1,2,3,4-tetrahydroisoquinoline-1,3-dione
2-hydroxyisoquinoline-1,3(2H,4H)-dione
6890-08-0
AC1LAHYL
ACN-049309
AJ-45130
AKOS016011468
AX8246098
BDBM33410
CHEMBL16755
DTXSID70333610
FCH1154656
KB-230940
N-hydroxyisoquinolinedione, 2
SCHEMBL3358267
ZINC3626195
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H7NO3
|
||||||||||||||||||
| Molecular Weight |
177.159
|
||||||||||||||||||
| Canonical SMILES |
ON1C(=O)Cc2ccccc2C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H7NO3/c11-8-5-6-3-1-2-4-7(6)9(12)10(8)13/h1-4,13H,5H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZXAICCBFIBBVAR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 2-hydroxyisoquinoline-1,3(2H,4H)-dione )
| Drug Name | 2-hydroxyisoquinoline-1,3(2H,4H)-dione | ||
|---|---|---|---|